Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fondation IUCPQ | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
The use of saturometry at home is more and more widespread in patients suffering from interstitial pulmonary diseases (IPD), the patients seeing it as reassurance and a concrete way to follow the evolution of their disease. However, there are no studies evaluating the real clinical benefit of taking saturation at home in this population. In addition, clinical experience seems rather to demonstrate an increase in the anxiety level and the number of clinically unnecessary consultations related to the use of this measure.
The secondary objectives are to determine the impact of this measurement on: (1) the health care use (telephone calls, medical consultations and hospitalizations), (2) dyspnea score, (3) the anxiety and depression score (HADS score) and (4) the physical activity level. The exploratory objectives will be to determine if the measurement of saturation at home makes it possible to (1) predict the occurrence of acute exacerbations of fibrosis, (2) effectively predict the decline in respiratory function tests and (3) 1-year mortality. The investigator will also assess whether this measure makes it possible to screen patients with oxygen therapy needs at home. The investigator hypothesize that measuring oxygen saturation at home will lead to a significant deterioration in quality of life, an increase in the use of health care, a significant increase in the rate of anxiety and depression, dyspnea and a decrease in the physical activity level.
Measurement tools
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention Group | Experimental | Intervention group participants will be asked to measure their oxygen saturation on a daily basis. |
|
| Control Group | No Intervention | Usual Care |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Saturation at home | Other | Clinical benefit of taking saturation at home in interstitial lung disease |
|
| Measure | Description | Time Frame |
|---|---|---|
| Quality of life by questionnaire | Impact of home base saturometry on quality of life | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Health care use (phone calls, medical consultation) | Impact of home base saturometry on health car use as number and principal reason for : telephone calls, medical consultations and hospitalizations. | 1 year |
| Dyspnea score |
| Measure | Description | Time Frame |
|---|---|---|
| Acute exacerbation | Impact of home base saturometry on predict the occurrence of acute exacerbations of fibrosis. Occurence: number of exacerbation of fibrosis during the year. | 1 year |
| Pulmonary function decline |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Geneviève Dion | Contact | 418-656-8711 | geneviève.dion@criucpq.ulaval.ca | |
| Jany Harvey, M.Sc. | Contact | 418-656-8711 | 5882 | jany.harvey@criucpq.ulaval.ca |
| Name | Affiliation | Role |
|---|---|---|
| Geneviève Dion, MD | Institut universitaire de pneumologie et cardiologue de Québec - ULaval | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec | Recruiting | Québec | G1V 4G5 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D017563 | Lung Diseases, Interstitial |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Impact of home base saturometry on dyspnea score with the University of California, San Diego Shortness of breath Questionnaire (UCSD) in a scale between 0 to 120 where 120 is the worst score.
| 1 year |
| Anxiety and depression score | Impact of home base saturometry on anxiety and depression score with the Hospital Anxiety and Depression Scale Questionnaire (HADs) in a scale between 0 to 42, where 42 is the worst score. | 1 year |
| Physical activity level | Impact of home base saturometry on physical activity level measure by accelerometer (McRoberts) and define by steps number. | 1 year |
| Energy expenditure | Impact of home base saturometry on energy expenditure (number of kilocalories burn by day), measure by accelerometer (McRoberts). | 1 year |
Impact of home base saturometry on predict the decline in respiratory function tests, principally the forced vital capacity.
| 1 year |
| Mortality | Impact of home base saturometry on 1-year mortality prediction | 1 year |